Eledon Pharmaceuticals Inc reports results for the quarter ended in March - Earnings Summary

Eledon Pharmaceuticals

13/05/2023 12:03

* Eledon Pharmaceuticals Inc  ELDN.OQ  reported a quarterly
adjusted loss of 75 cents​​ per share for the quarter ended in
March. The mean expectation of three analysts for the quarter
was for a loss of 60 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Eledon Pharmaceuticals Inc's reported EPS for the quarter
was a
loss of 75 cents​.
    * The mean earnings estimate of analysts had fallen by
about 28.8%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Eledon Pharmaceuticals Inc shares had risen by 17.4% this
quarter and gained 21.5% so far this year.
    * The company reported a quarterly loss of $10.77 million.
    * Wall Street's median 12-month price target for Eledon
Pharmaceuticals Inc is $12.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data May
13 at 11:03 a.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2023      -0.60          -0.75          Missed
 Dec. 31 2022      -0.70          -0.69          Beat
 Sep. 30 2022      -0.68          -0.73          Missed
 Jun. 30 2022      -0.70          -0.65          Beat